Приказ основних података о документу
Development and evaluation of Y-90-labeled albumin microspheres loaded with magnetite nanoparticles for possible applications in cancer therapy
dc.creator | Radović, Magdalena | |
dc.creator | Vranješ-Đurić, Sanja | |
dc.creator | Nikolić, Nadežda S. | |
dc.creator | Janković, Drina | |
dc.creator | Goya, Gerardo F. | |
dc.creator | Torres, Teobaldo E. | |
dc.creator | Calatayud, Maria Pilar | |
dc.creator | Bruvera, Ignacio J. | |
dc.creator | Ibarra, M. Ricardo | |
dc.creator | Spasojević, Vojislav | |
dc.creator | Jančar, Boštjan | |
dc.creator | Antić, Bratislav | |
dc.date.accessioned | 2018-03-01T22:57:53Z | |
dc.date.available | 2018-03-01T22:57:53Z | |
dc.date.issued | 2012 | |
dc.identifier.issn | 0959-9428 | |
dc.identifier.uri | https://vinar.vin.bg.ac.rs/handle/123456789/5175 | |
dc.description.abstract | Radio labeled albumin microspheres with encapsulated citric acid-coated magnetite nanoparticles were developed as a targeting approach to localize both radioactivity and magnetic energy at the tumor site. We present in vitro and in vivo studies of yttrium-90 (Y-90)-labeled human scrum albumin magnetic microspheres (HSAMMS) as a multifunctional agent for possible applications in a bimodal radionuclide-hyperthermia cancer therapy. The HSAMMS were produced using a modified emulsification-heat stabilization technique and contained 11 nm magnetite nanoparticles coated with citric acid, distributed as inhomogeneous clusters within the albumin microspheres. The size, size distribution and the morphology of magnetite nanoparticles and HSAMMS were determined by FESEM, HRTEM and SEM/FIB dual beam. The average particle size of the complete HSAMMS was 20 mu m, and they exhibited superparamagnetic behavior at room temperature. The in vitro experiments (in saline and human serum) revealed the high stability of the labeled HSAMMS in saline and human serum after 72 h. Following the intravenous administration of the Y-90-HSAMMS in rats, 88.81% of the activity localizes in the lungs after 1 h, with 82.67% remaining after 72 h. These data on Y-90-HSAMMS provide good evidence for their potential use in bimodal radionuclide-hyperthermia cancer therapy. | en |
dc.relation | info:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/45015/RS// | |
dc.relation | Spanish Ministry of Education, Spanish Ministerio de Ciencia e Innovacion [MAT2010-19326] | |
dc.rights | restrictedAccess | en |
dc.source | Journal of Materials Chemistry | en |
dc.title | Development and evaluation of Y-90-labeled albumin microspheres loaded with magnetite nanoparticles for possible applications in cancer therapy | en |
dc.type | article | en |
dcterms.abstract | Брувера, Игнацио Ј.; Ибарра, М. Рицардо; Јанцар, Бостјан; Гоyа, Герардо Ф.; Aнтић Братислав; Спасојевић Војислав; Николиц, Надезда; Цалатаyуд, М. Пилар; Радовић Магдалена; Врањеш-Дјурић Сања; Јанковић Дрина; Торрес, Теобалдо Е.; | |
dc.citation.volume | 22 | |
dc.citation.issue | 45 | |
dc.citation.spage | 24017 | |
dc.citation.epage | 24025 | |
dc.identifier.wos | 000311522500040 | |
dc.identifier.doi | 10.1039/c2jm35593k | |
dc.citation.rank | M21a | |
dc.identifier.scopus | 2-s2.0-84868138300 |
Документи
Датотеке | Величина | Формат | Преглед |
---|---|---|---|
Уз овај запис нема датотека. |